The authors regret (changes marked in bold): Arianne J.H. van Velthoven a b, Tor P. Utheim M.D. Dr. c d, Maria Notara Dr. e, Dominique Bremond-Gignac M.D. Dr. f g, Francisco C. Figueiredo M.D. Dr. h i, Heli Skottman Dr. j, Daniel Aberdam Dr. g, Julie T. Daniels Dr. k, Giulio Ferrari M.D. Dr. l m, Christina Grupcheva M.D. Dr. n, Carina Koppen M.D. Dr. °, Mohit Parekh Dr. p, Thomas Ritter Dr. q, Vito Romano Dr. r, Stefano Ferrari Dr. s 1, Claus Cursiefen M.D. Dr. e t 1, Neil Lagali Dr. u 1, Vanessa L.S. LaPointe Dr. a 1, Mor M. Dickman M.D. Dr. a b 1 a MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands b University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands c Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway d Department of Ophthalmology, Oslo University Hospital, Oslo, Norway e Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany f Ophthalmology Department, University Hospital Necker-Enfants Malades, APHP, Paris Cité University, Paris, France g Centre de Recherche des Cordeliers, Sorbonne Paris Cité University, Paris, France h Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK i Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK j Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland k UCL Institute of Ophthalmology, London, UK l IRCCS San Raffaele Scientific Institute, Division of Neuroscience, Cornea and Ocular Surface Disease Unit, Eye Repair Lab, Milan, Italym Vita-Salute San Raffaele University, Dept. Of Ophthalmology, Milan, Italyn Department of Ophthalmology and Visual Sciences, Medical University of Varna, Varna, Bulgaria o Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium p Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA q Regenerative Medicine Institute, University of Galway, Galway, Ireland r Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy s Fondazione Banca degli Occhi del Veneto, Venice, Italy t Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany u Division of Ophthalmology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden The authors would like to apologise for any inconvenience caused
Future directions in managing aniridia-associated keratopathy / Van Velthoven, A. J. H.; Utheim, T. P.; Notara, M.; Bremond-Gignac, D.; Figueiredo, F. C.; Skottman, H.; Aberdam, D.; Daniels, J. T.; Ferrari, G.; Grupcheva, C.; Koppen, C.; Parekh, M.; Ritter, T.; Romano, V.; Ferrari, S.; Cursiefen, C.; Lagali, N.; Lapointe, V. L. S.; Dickman, M. M.. - In: SURVEY OF OPHTHALMOLOGY. - ISSN 0039-6257. - 69:2(2024), pp. 300-301. [10.1016/j.survophthal.2024.01.001]
Future directions in managing aniridia-associated keratopathy
Ferrari G.;Ferrari S.;
2024-01-01
Abstract
The authors regret (changes marked in bold): Arianne J.H. van Velthoven a b, Tor P. Utheim M.D. Dr. c d, Maria Notara Dr. e, Dominique Bremond-Gignac M.D. Dr. f g, Francisco C. Figueiredo M.D. Dr. h i, Heli Skottman Dr. j, Daniel Aberdam Dr. g, Julie T. Daniels Dr. k, Giulio Ferrari M.D. Dr. l m, Christina Grupcheva M.D. Dr. n, Carina Koppen M.D. Dr. °, Mohit Parekh Dr. p, Thomas Ritter Dr. q, Vito Romano Dr. r, Stefano Ferrari Dr. s 1, Claus Cursiefen M.D. Dr. e t 1, Neil Lagali Dr. u 1, Vanessa L.S. LaPointe Dr. a 1, Mor M. Dickman M.D. Dr. a b 1 a MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands b University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands c Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway d Department of Ophthalmology, Oslo University Hospital, Oslo, Norway e Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany f Ophthalmology Department, University Hospital Necker-Enfants Malades, APHP, Paris Cité University, Paris, France g Centre de Recherche des Cordeliers, Sorbonne Paris Cité University, Paris, France h Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK i Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK j Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland k UCL Institute of Ophthalmology, London, UK l IRCCS San Raffaele Scientific Institute, Division of Neuroscience, Cornea and Ocular Surface Disease Unit, Eye Repair Lab, Milan, Italym Vita-Salute San Raffaele University, Dept. Of Ophthalmology, Milan, Italyn Department of Ophthalmology and Visual Sciences, Medical University of Varna, Varna, Bulgaria o Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium p Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA q Regenerative Medicine Institute, University of Galway, Galway, Ireland r Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy s Fondazione Banca degli Occhi del Veneto, Venice, Italy t Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany u Division of Ophthalmology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden The authors would like to apologise for any inconvenience caused| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0039625724000018.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
278.93 kB
Formato
Adobe PDF
|
278.93 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


